Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CAT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LOC101929243 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
SERP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BAG2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CTSC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPS3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AMZ2P1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NADK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TTC9C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MADD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR7113 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EXTL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CD59 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR6758 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OAS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DENR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NUP160 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARNTL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TXNDC15 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on